On December 30th 2020, the UK was the first country to approve the Oxford-AstraZeneca’s vaccine after months of clinical trials. Oxford University’s Jenner Institute first joined forces with private company Vaccitech before the Oxford Vaccine Group stepped in too.
The acclaimed university received funding from the UK and US governments and signed a licensing agreement with AstraZeneca in May 2020.
According to Boris Johnson’s Government, over £88m of public money has been invested in developing and manufacturing the vaccine overall.
The British Prime Minister released a statement congratulating the scientists behind the trailblazing vaccine a year later.
Boris Johnson said: “Our fight against Covid in the UK and around the world would not have been possible without the Oxford-AstraZeneca vaccine.
“Developed by brilliant scientists at Oxford and delivered on a not-for-profit basis thanks to AstraZeneca, this vaccine has provided 50m doses to the British public and over 2.5bn to more than 170 other countries.
“We can all be incredibly proud of – and grateful for – a jab that has saved many millions of lives.”
Used worldwide, the Oxford-AstraZeneca’s vaccine has been approved by the World Health Organisation (WHO) and the European Medicines Agency (EMA).
After reports showed a possible link between the dose of vaccine and blood clots, the WHO reviewed the claims and stated the vaccine’s benefits outweigh its potential risks.
READ MORE: Spain in the grips of Omicron as cases smash records
He added: “I’m incredibly proud of the role the UK has played in developing, researching and manufacturing ground-breaking vaccines and treatments during the pandemic.”
“Vaccines are the best way to protect people from COVID-19, and I’m urging everybody to play their part in this national mission – roll up your sleeves and get your jabs.”